FIELD: organic chemistry.
SUBSTANCE: invention relates to a heterocyclic compound of formula (IIII-AZ), where R5a is methyl, AZ is
,
V1 is selected from valyl-citrulline, valyl-lysine, phenylalanyl-lysine, alanyl-phenylalanyl-lysine and D-alanyl-phenylalanyl-lysine,
CL is
L is selected from , q varies from 1 to 4, and Ab is selected from CD19 antibody, CD22 antibody, CD30 antibodies, CD33 antibodies, CD56 antibodies, CD70 antibodies, CD74 antibodies, CD138 antibodies, CLL-1 antibodies, 5T4 antibodies, CD303 antibodies, Tag 72 antibodies, carbohydrate similar to Lewis A antibodies, EphB3 antibodies, HMW-MAA antibodies, CD38 antibodies, Cripto antibodies, EphA2 antibodies, GPNMB antibodies, integrin antibodies, MN antibodies, Her2 antibodies and PSMA antibodies or epitope-binding fragment or derivative of any of them. Invention also relates to use of the compound of formula (III-AZ) as a drug for treating or preventing tumor in a mammal.
EFFECT: obtaining novel conjugates useful for treating a tumor.
4 cl, 7 dwg, 16 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL CONJUGATES OF CC-1065 ANALOGUES AND BIFUNCTIONAL LINKERS | 2011 |
|
RU2578719C9 |
NEW CC-1065 ANALOGS AND THEIR CONJUGATES | 2009 |
|
RU2628069C2 |
WATER-SOLUBLE ANALOGUES CC-1065 AND THEIR CONJUGATES | 2007 |
|
RU2489423C2 |
NOVEL CC-1065 ANALOGUES AND THEIR CONJUGATES | 2009 |
|
RU2562232C2 |
ANTI-CD22 ANTIBODY-MAITANSIN CONJUGATES AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2744895C2 |
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
ANTIBODY DRUG CONJUGATES | 2014 |
|
RU2669812C2 |
CHEMICAL LINKERS AND CONJUGATES THEREOF | 2005 |
|
RU2402548C2 |
NON-STEROIDAL MODULATORS OF PROGESTERONE RECEPTOR | 2003 |
|
RU2309155C2 |
Authors
Dates
2020-08-24—Published
2011-04-21—Filed